Patents by Inventor Thorsten Lehmann-Lintz

Thorsten Lehmann-Lintz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
    Publication number: 20050234101
    Abstract: Alkyne compounds having MCH-receptor antagonistic activity, which are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.
    Type: Application
    Filed: April 13, 2005
    Publication date: October 20, 2005
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Dirk Stenkamp, Stephan Mueller, Philipp Lustenberger, Thorsten Lehmann-Lintz, Gerald Roth, Klaus Rudolf, Marcus Schindler, Leo Thomas, Ralf Lotz
  • Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
    Publication number: 20050054710
    Abstract: The present invention relates to heterocyclically substituted indolinones of general formula wherein R1 to R5 and X are defined as in claim 1, the tautomers, the diastereomers, the enantiomers, the mixtures thereof, the prodrugs thereof and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable pharmacological properties, in particular an inhibiting effect on various receptor tyrosine kinases and cyclin/CDK complexes and on the proliferation of endothelial cells and various tumour cells, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
    Type: Application
    Filed: September 5, 2003
    Publication date: March 10, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Joerg Kley, Frank Hilberg, Armin Heckel, Gerald Roth, Thorsten Lehmann-Lintz, Ralf Lotz, Ulrike Tontsch-Grunt, Jacobus Van Meel
  • Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
    Publication number: 20050043389
    Abstract: The present invention relates to indolinone derivatives, substituted in the 6-position, of the formula in which R1 to R6 and X are as defined in claim 1, to their tautomers, enantiomers, diastereomers, to their mixtures and to their salts, in particular their physiologically acceptable salts, which have useful pharmacological properties, in particular in inhibiting action on various receptor tyrosine kinases and on the proliferation of endothelial cells and various tumour cells, to medicaments comprising these compounds, to their use and to processes for their preparation.
    Type: Application
    Filed: July 22, 2003
    Publication date: February 24, 2005
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Gerald Roth, Armin Heckel, Thorsten Lehmann-Lintz, Joerg Kley, Frank Hilberg, Jacobus Van Meel, Ulrike Tontsch-Grunt
  • Substituted indolinones
    Patent number: 6858641
    Abstract: The present invention relates to indolinones substituted in the 6-position of general formula wherein R1 to R5 and X are defined as in claim 1, the isomers and the salts thereof, particularly the physiologically acceptable salts thereof which have valuable pharmacological properties, in particular an inhibiting effect on various receptor tyrosine kinases and cyclin/CDK complexes and on the proliferation of endothelial cells and various, pharmaceutical compositions containing these compounds, their use and processes for preparing them.
    Type: Grant
    Filed: April 4, 2002
    Date of Patent: February 22, 2005
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Gerald Juergen Roth, Armin Heckel, Thorsten Lehmann-Lintz, Joerg Kley, Frank Hilberg, Jacobus Van Meel
  • New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
    Publication number: 20040242572
    Abstract: The present invention relates to carboxamide compounds of general formula I 1
    Type: Application
    Filed: August 22, 2003
    Publication date: December 2, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Dirk Stenkamp, Martin Lenter, Heike-Andrea Wieland, Klaus Rudolf, Stephan George Mueller, Ralf R.H. Lotz, Kirsten Arndt, Philipp Lustenberger, Thorsten Lehmann-Lintz
  • Substituted piperazine derivatives, the preparation thereof and their use as medicaments
    Patent number: 6821967
    Abstract: The present invention relates to substituted piperazine derivatives of general formula wherein Ra, Rb, Rc, Rf, Rg, X, m and n are defined as in claim 1, the isomers and salts thereof, particularly the physiologically acceptable salts thereof, which are valuable inhibitors of the microsomal triglyceride-transfer protein (MTP), medicaments containing these compounds and their use, as well as the preparation thereof.
    Type: Grant
    Filed: October 9, 2002
    Date of Patent: November 23, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Thorsten Lehmann-Lintz, Armin Heckel, Leo Thomas, Michael Mark
  • Substituted piperazine derivatives, the preparation thereof and their use as medicaments
    Patent number: 6818644
    Abstract: The present invention relates to substituted piperazine derivatives of general formula wherein Ra, Rb, Rc Rf, Rg and m, n and X are defined as in claim 1, the isomers and salts thereof, particularly the physiologically acceptable salts thereof, which are valuable inhibitors of the microsomal triglyseride-transfer protein (MTP), medicaments containing these compounds and their use, as well as the preparation thereof.
    Type: Grant
    Filed: July 1, 2002
    Date of Patent: November 16, 2004
    Assignee: Boehringer Ingelheim Pharm GmbH & Co, KG
    Inventors: Thorsten Lehmann-Lintz, Armin Heckel, Leo Thomas, Michael Mark
  • Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
    Publication number: 20040209865
    Abstract: The present invention relates to alkyne compounds of general formula I 1
    Type: Application
    Filed: October 30, 2003
    Publication date: October 21, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Dirk Stenkamp, Stephan Georg Mueller, Gerald Juergen Roth, Thorsten Lehmann-Lintz, Klaus Rudolf, Philipp Lustenberger, Kirsten Arndt, Ralf R.H. Lotz, Martin Lenter
  • Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
    Patent number: 6806272
    Abstract: The present invention relates to new dihydropteridinones of the formula (I) wherein the groups X, R1, R2, R3, R4, R5 and R7 have the meanings given in the claims and the specification, the isomers thereof, processes and intermediates for preparing these dihydropteridinones as well as the use thereof as pharmaceutical compositions.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: October 19, 2004
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Eckhart Bauer, Steffen Breitfelder, Christian Eickmeier, Matthias Grauert, Matthias Hoffmann, Thorsten Lehmann-Lintz, Gerald Pohl, Jens Quant, Norbert Redemann, Gisela Schnapp, Martin Steegmaier
  • Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
    Publication number: 20040152742
    Abstract: The present invention relates to amide compounds of general formula I 1
    Type: Application
    Filed: October 31, 2003
    Publication date: August 5, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Dirk Stenkamp, Stephan Georg Mueller, Gerald Juergen Roth, Philipp Lustenberger, Klaus Rudolf, Thorsten Lehmann-Lintz, Kirsten Arndt, Ralf Lotz, Martin Lenter, Heike-Andrea Wieland
  • Methods of using dihydropteridinones
    Publication number: 20040147524
    Abstract: Disclosed are dihydropteridinones of the formula (I): 1
    Type: Application
    Filed: January 13, 2004
    Publication date: July 29, 2004
    Applicant: Boehringer Ingelheim Pharma Gmbh & Co. KG
    Inventors: Eckhart Bauer, Steffen Breitfelder, Christian Eickmeier, Matthias Grauert, Matthias Hoffmann, Thorsten Lehmann-Lintz, Gerald Phol, Jens Quant, Norbert Redemann, Gisela Schnapp, Martin Steegmaier
  • New dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
    Publication number: 20040029885
    Abstract: The present invention relates to new dihydropteridinones of the formula (I) 1
    Type: Application
    Filed: August 23, 2002
    Publication date: February 12, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Eckhart Bauer, Steffen Breitfelder, Christian Eickmeier, Matthias Grauert, Matthias Hoffmann, Thorsten Lehmann-Lintz, Gerald Pohl, Jens Quant, Norbert Redemann, Gisela Schnapp, Martin Steegmaier
  • Biphenyl derivatives, production thereof and uses as medicines
    Patent number: 6617325
    Abstract: The present invention relates to biphenyl derivatives of general formula wherein Ra to Rg and n are defined as in claim 1, the isomers and salts thereof, particularly the physiologically acceptable salts thereof, which are valuable inhibitors of the microsomal triglyceride-transfer protein (MTP), medicaments containing these compounds and their use, as well as the preparation thereof.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: September 9, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Thorsten Lehmann-Lintz, Armin Heckel, Leo Thomas, Michael Mark
  • Substituted piperazine derivatives, the preparation thereofand their use as medicaments
    Publication number: 20030166637
    Abstract: The present invention relates to substituted piperazine derivatives of general formula 1
    Type: Application
    Filed: October 9, 2002
    Publication date: September 4, 2003
    Inventors: Thorsten Lehmann-Lintz, Armin Heckel, Leo Thomas, Michael Mark
  • Substituted piperazine derivatives as mtp inhibitors
    Publication number: 20030114442
    Abstract: The present invention relates to substituted piperazine derivatives of general formula 1
    Type: Application
    Filed: October 8, 2002
    Publication date: June 19, 2003
    Inventors: Armin Heckel, Thorsten Lehmann-Lintz, Leo Thomas, Michael Mark
  • Substituted indolinones
    Publication number: 20030092756
    Abstract: The present invention relates to indolinones substituted in the 6-position of general formula 1
    Type: Application
    Filed: April 4, 2002
    Publication date: May 15, 2003
    Inventors: Gerald Juergen Roth, Armin Heckel, Thorsten Lehmann-Lintz, Joerg Kley, Frank Hilberg, Jacobus Van Meel